Search

Search Results
Results 31 - 40 of 51 for Abuse potential
  • Drug - 8 Oct 2024
    Consumer Medicine Information (CMI) about Bisolvon Dry Oral Liquid intended for persons living in Australia.
  • Drug - 4 Oct 2024
    Consumer Medicine Information (CMI) about Methylphenidate-Teva XR intended for persons living in Australia.
  • Drug - 18 Sep 2024
    Consumer Medicine Information (CMI) about Antenex intended for persons living in Australia.
  • Drug - 10 Sep 2024
    Consumer Medicine Information (CMI) about DBL Morphine Sulfate intended for persons living in Australia.
  • Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Ketalar intended for persons living in Australia.
  • Drug - 21 Aug 2024
    Consumer Medicine Information (CMI) about Bisolvon Dry Pastilles intended for persons living in Australia.
  • Drug - 19 Aug 2024
    Consumer Medicine Information (CMI) about Lyzalon intended for persons living in Australia.
  • Drug - 29 Jul 2024
    Consumer Medicine Information (CMI) about Mayne Pharma Oxycodone IR intended for persons living in Australia.
  • Drug - 29 Feb 2024
    Consumer Medicine Information (CMI) about Somidem intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Methylphenidate XR ARX intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.